Transforming growth factor-β (TGF-β) is a key molecule, which is responsible for glioblastoma-mediated immunosuppression; programmed cell death protein 1 (PD-1) is neutralizing antibodies to immune checkpoint molecules and is now leading in the field of cancer immunotherapy. The gene discussed is PDCD1; the disease is glioblastoma.